Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

423
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
423
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

359
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
359
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

585
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
585
Synthetic Biology02:55

Synthetic Biology

4.4K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
4.4K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.5K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.5K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

725
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
725

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The energetic costs of escaping predation in wild, schooling white mullet (Mugil curema).

The Journal of experimental biology·2026
Same author

ATM Deficiency Induces TGF-β-Mediated Stromal Programming in Pancreatic Cancer.

Cancer research·2026
Same author

Dual-cycle CO<sub>2</sub> fixation enhances growth and lipid synthesis in <i>Arabidopsis thaliana</i>.

Science (New York, N.Y.)·2025
Same author

Towards the yin and yang of fish locomotion: linking energetics, ecology and mechanics through field and lab approaches.

The Journal of experimental biology·2025
Same author

Filter feeding in devil rays is highly sensitive to morphology.

Proceedings. Biological sciences·2025
Same author

Prognostic value of neutrophil-to-lymphocyte ratios pre- and post-surgery in stage III CRC: a study of 2,742 patients.

International journal of colorectal disease·2024

Related Experiment Video

Updated: Apr 27, 2026

High-Throughput Metabolic Profiling for Model Refinements of Microalgae
11:07

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

Published on: December 4, 2021

3.6K

Ensemble Modeling for Robustness Analysis in engineering non-native metabolic pathways.

Yun Lee1, Jimmy G Lafontaine Rivera1, James C Liao2

  • 1Department of Chemical and Biomolecular Engineering, University of California, 5531 Boelter Hall, Los Angeles, CA 90095, USA.

Metabolic Engineering
|June 28, 2014
PubMed
Summary
This summary is machine-generated.

Biological pathways need robustness to handle cellular changes. Ensemble Modeling for Robustness Analysis (EMRA) assesses pathway stability, revealing that synthetic metabolic pathways exhibit varying robustness, impacting system performance.

Keywords:
Ensemble ModelingMetabolic engineeringRobustnessSynthetic biology

More Related Videos

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Single-throughput Complementary High-resolution Analytical Techniques for Characterizing Complex Natural Organic Matter Mixtures
09:38

Single-throughput Complementary High-resolution Analytical Techniques for Characterizing Complex Natural Organic Matter Mixtures

Published on: January 7, 2019

7.4K

Related Experiment Videos

Last Updated: Apr 27, 2026

High-Throughput Metabolic Profiling for Model Refinements of Microalgae
11:07

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

Published on: December 4, 2021

3.6K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Single-throughput Complementary High-resolution Analytical Techniques for Characterizing Complex Natural Organic Matter Mixtures
09:38

Single-throughput Complementary High-resolution Analytical Techniques for Characterizing Complex Natural Organic Matter Mixtures

Published on: January 7, 2019

7.4K

Area of Science:

  • Systems Biology
  • Metabolic Engineering

Background:

  • Cellular metabolic pathways require robustness to maintain stability despite fluctuations in expression levels and environmental conditions.
  • Network structures in biological systems often evolve for intrinsic robustness.
  • Perturbations can lead to system failure by destabilizing steady states.

Purpose of the Study:

  • To introduce Ensemble Modeling for Robustness Analysis (EMRA) for assessing the robustness of non-native metabolic pathways.
  • To investigate the bifurcational robustness of synthetic central metabolic pathways.

Main Methods:

  • EMRA combines a continuation method with Ensemble Modeling.
  • It analyzes large parameter ensembles to identify bifurcation points leading to system failure.
  • Bifurcational robustness is quantified by the probability of system failure within the ensemble.

Main Results:

  • EMRA was used to evaluate two synthetic carbon-conserving pathways: non-oxidative glycolysis and the reverse glyoxylate cycle.
  • The study determined the probability of system failure for each pathway design.
  • Alternative pathway designs demonstrated varying degrees of bifurcational robustness.

Conclusions:

  • Synthetic metabolic pathways exhibit different levels of robustness.
  • Optimizing flux in metabolic pathways requires balancing robustness and performance.
  • EMRA provides a quantitative method for assessing pathway robustness in synthetic biology.